GSK’s RSV vaccine shows positive data on efficacy in older adults
HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.
HQ Team June 21, 2023: Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to.
HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.
HQ Team June 20, 2023: Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set.
HQ Team June 20, 2023: Eli Lilly and Company will acquire Dice Therapeutics for $2.4 billion to expand its immunology business, according to an.
HQ Team June 20, 2023: Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s.
HQ Team June 20, 2023: The toxicity rate related to benzodiazepine, a drug used to treat insomnia and anxiety and doubles up as.
HQ Team June 17, 2023: Access to pain relief medication, morphine, is ‘one of the most heinous, hidden inequities in global health’ with.
HQ Team June 17, 2023: The UN has adopted a new manifesto, the Rabat Declaration, to strengthen the global commitment to improve the health.
HQ Team June 16, 2023: Cancer has been striking young people more in recent times. A recent study in Nature dubs it the early-onset cancer.